Changing clinical outcomes with more intensive platelet inhibition

1 September 2019 (13:17 - 13:29)

Organised by:

Video

Slides

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)

5 More presentations in this session

Welcome and Introduction

Professor L. Wallentin (Uppsala, SE)

Slides Video

Manipulating the platelet - Successes and failures

Professor R. Storey (Sheffield, GB)

Slides Video

Effects in various clinical settings, patient subsets and healthcare realities

Professor S. James (Uppsala, SE)

Slides Video

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

Professor L. Wallentin (Uppsala, SE) Professor C. Cannon (Boston, US) Professor R. Storey (Sheffield, GB) Professor S. James (Uppsala, SE) Professor R. Mehran (New York City, US)

Slides

Summary and close

Professor R. Mehran (New York City, US)

Slides Video

Access the full session

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

The Event

ESC Congress 2019

1 September 2019 13:17 CET

You may be interested in

Congress Session

State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

14 March 2025

Congress Presentation

Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI

30 August 2025

Congress Presentation

Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting

26 August 2023

Congress Presentation

Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital

21 March 2026

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

ESC 365 is supported by

Explore sponsored resources